Tag #Weight Loss

Showing 85 to 96 of 116 results

dw.com

🌐 75% Global Worthiness

Jan 28, 22:12

GLP-1 RA Drugs Show Promise, but Limitations Remain

A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...

GLP-1 RA Drugs Show Promise, but Limitations Remain

A study of 1.2 million medical records found that GLP-1 RA drugs, such as Ozempic and Wegovy, may reduce the risk of several health issues, including substance use disorders, psychiatric disorders, and dementia, by 8-18%, but also carry risks of nausea, vomiting, and pancreatic or kidney complicatio...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the broader systemic implications of this study's findings considering its limitations in sample representation and study design?

The study focused on GLP-1 receptor agonists (GLP-1 RAs), a class of drugs that includes Ozempic and Wegovy. These drugs affect brain receptors involved in impulse control, reward, and addiction, potentially explaining their impact on appetite and addiction disorders. The observed benefits were linked to the drugs' ability to reduce blood glucose levels and slow intestinal emptying.

dw.com

🌐 75% Global Worthiness

Jan 27, 13:09

Diabetes Drugs Linked to Reduced Risk of Mental Health Issues

A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...

Diabetes Drugs Linked to Reduced Risk of Mental Health Issues

A study of 1.2 million veterans' medical records found that the diabetes and weight-loss drugs Ozempic and Wegovy (GLP-1 receptor agonists) may be linked to a reduced risk of various mental health issues, including alcohol and substance use disorders, suicidal thoughts, schizophrenia, dementia, and ...

Progress

24% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of this study, and what additional research is needed to explore potential therapeutic uses of GLP-1 RAs for mental health conditions?

Future research should focus on randomized controlled trials to confirm these findings and investigate the underlying mechanisms. The study's limitations, such as the predominantly white male veteran population, highlight the need for further investigation across diverse populations to determine the generalizability of these results. Understanding the precise impact of GLP-1 RAs on different neurological pathways will be crucial for potential therapeutic applications.

nos.nl

🌐 85% Global Worthiness

Jan 23, 22:08

Bariatric Surgery: A Last Resort for Severely Obese Children in the Netherlands

A scientific study in the Netherlands provides bariatric surgery to six obese children (13+) as a last resort after failed lifestyle interventions, addressing the rising rates of childhood obesity (12% overweight, 4.1% severely obese among 4-17 year olds) and its severe health consequences.

Bariatric Surgery: A Last Resort for Severely Obese Children in the Netherlands

A scientific study in the Netherlands provides bariatric surgery to six obese children (13+) as a last resort after failed lifestyle interventions, addressing the rising rates of childhood obesity (12% overweight, 4.1% severely obese among 4-17 year olds) and its severe health consequences.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate health consequences of childhood obesity in the Netherlands, and what drastic measures are being taken to address the most severe cases?

In the Netherlands, six obese children have undergone successful weight-loss surgery as part of a research study. This is considered a last resort, following unsuccessful lifestyle interventions. The surgery is only offered to children with a BMI over 35, multiple chronic conditions, and who have completed puberty.

faz.net

🌐 85% Global Worthiness

Jan 21, 10:09

GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study

A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.

GLP-1 Receptor Agonists: Significant Health Benefits and Risks Revealed in Large-Scale Study

A study of 1.4 million US veterans with type 2 diabetes showed that GLP-1 receptor agonists, weekly-injected drugs, reduced the risk of 42 health issues but increased the risk of 19 others, highlighting both benefits and risks of this increasingly popular medication.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the mechanisms of action of GLP-1 receptor agonists explain their effects on appetite, addiction, and cognitive function?

The positive effects observed in the study are linked to the drugs' action on brain receptors involved in impulse control, reward, and addiction, explaining their efficacy in curbing appetite and treating addiction. The reduced dementia risk may be due to the drugs' anti-inflammatory effects in the brain.

cnbc.com

🌐 85% Global Worthiness

Jan 14, 22:08

Eli Lilly Stock Tumbles Despite Positive 2025 Outlook

Eli Lilly's stock fell over 7% on Tuesday after the company lowered its 2024 revenue outlook due to disappointing fourth-quarter sales of its GLP-1 weight-loss and diabetes drugs, Mounjaro and Zepbound, which missed estimates by a combined $500 million, despite resolving supply chain issues and main...

Eli Lilly Stock Tumbles Despite Positive 2025 Outlook

Eli Lilly's stock fell over 7% on Tuesday after the company lowered its 2024 revenue outlook due to disappointing fourth-quarter sales of its GLP-1 weight-loss and diabetes drugs, Mounjaro and Zepbound, which missed estimates by a combined $500 million, despite resolving supply chain issues and main...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What caused Eli Lilly's stock to plummet on Tuesday, and what are the immediate consequences of this decline?

Eli Lilly's stock dropped over 7% on Tuesday due to lowered 2024 revenue projections, primarily caused by underperforming sales of its GLP-1 weight-loss and diabetes drugs, Mounjaro and Zepbound. The shortfall, approximately $400 million below expectations, resulted in a revised revenue outlook of around $13.5 billion for the fourth quarter, missing Wall Street estimates by $400 million.

bbc.com

🌐 65% Global Worthiness

Dec 31, 10:09

Derby Football League Spurs Significant Weight Loss

A Derby, England, weight-loss football league, MAN v FAT, helped 47 players lose a combined 235kg (37 stone) in 2024, with some participants losing over a fifth of their body weight, improving their health and well-being.

Derby Football League Spurs Significant Weight Loss

A Derby, England, weight-loss football league, MAN v FAT, helped 47 players lose a combined 235kg (37 stone) in 2024, with some participants losing over a fifth of their body weight, improving their health and well-being.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the MAN v FAT program's unique combination of football and weight loss contribute to its effectiveness?

MAN v FAT's success stems from its unique approach: combining competitive football with weight-loss goals. This motivates men, who often have a strong desire to win, to prioritize their health. The league's impact is substantial; in Derby alone, 47 players lost a combined 235kg (37 stone) in 2024.

dw.com

🌐 75% Global Worthiness

Jan 27, 13:09

GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions

A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...

GLP-1RA Drugs Show Potential Link to Reduced Risk of Mental Health and Cognitive Conditions

A study of over 1.2 million veterans' medical records suggests a possible link between GLP-1 receptor agonist drugs, such as Ozempic and Wegovy, and a reduced risk of various mental health conditions, including suicidal thoughts, schizophrenia, dementia, and Alzheimer's disease, although further res...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How might the mechanisms of action of GLP-1RA drugs explain their potential impact on mental health and addiction?

The observed association between GLP-1RA use and reduced risk of mental health and cognitive decline issues may be linked to the drugs' impact on brain receptors involved in impulse control and reward. This is an observational study, however, so it doesn't establish causality, and further research is needed to confirm these findings and understand the underlying mechanisms.

foxnews.com

🌐 85% Global Worthiness

Jan 23, 13:10

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study

A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the mechanisms of action of GLP-1 drugs explain their observed effects on both cognitive function and addiction?

The study, published in Nature, establishes widespread associations between GLP-1 agonists and various health outcomes. These drugs impact brain receptors related to impulse control, reducing cravings. Weight loss and decreased brain inflammation are suggested as mechanisms for improved cognitive health.

smh.com.au

🌐 85% Global Worthiness

Jan 21, 04:08

GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed

A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.

GLP-1 Weight-Loss Drugs: Significant Health Benefits and Risks Revealed

A study of over 2.4 million people found that GLP-1 weight-loss medications reduced the risk of 42 health conditions, including cardiac arrest and Alzheimer's disease, by reducing inflammation and improving impulse control, but increased risks of gastrointestinal issues were also observed.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most significant health benefits and risks associated with GLP-1 weight-loss medications, according to this large-scale study?

A major study analyzing 2.4 million health records revealed that GLP-1 weight-loss medications, such as Ozempic and Wegovy, reduced the risk of over 40 health conditions, including cardiac arrest (22%), pneumonia (16%), and Alzheimer's (12%). However, increased risks of nausea, headaches, and abdominal pain were also observed.

theguardian.com

🌐 85% Global Worthiness

Jan 20, 22:10

GLP-1RA Medications: Reduced Risk of 42 Conditions, Increased Risk of 19 in Diabetic Patients

A study of 215,970 diabetic patients found GLP-1RA medications reduced the risk of 42 conditions (including psychotic disorders and dementia) by 13-19%, but increased the risk of 19 others (such as arthritis), based on a 3.5-year analysis of US Department of Veterans Affairs data.

GLP-1RA Medications: Reduced Risk of 42 Conditions, Increased Risk of 19 in Diabetic Patients

A study of 215,970 diabetic patients found GLP-1RA medications reduced the risk of 42 conditions (including psychotic disorders and dementia) by 13-19%, but increased the risk of 19 others (such as arthritis), based on a 3.5-year analysis of US Department of Veterans Affairs data.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the observed risks and benefits of GLP-1RAs compare to those of other anti-diabetic medications?

Researchers compared GLP-1RA users to those receiving standard diabetes care, analyzing data from the US Department of Veterans Affairs. The results showed a significant decrease in the risk of various conditions, but also revealed an increased risk of others. This comprehensive analysis involved tracking participants for approximately 3.5 years, with an average BMI above the obesity threshold.

cnbc.com

🌐 85% Global Worthiness

Jan 11, 22:06

Virta Health's 60% Revenue Surge Driven by Employer Demand for Cost-Effective Weight Loss Solutions

Virta Health, a digital diabetes and weight loss program, achieved 60% revenue growth in 2024, exceeding $100 million, due to increasing employer demand for cost-effective alternatives to expensive GLP-1 drugs; the company's nutrition-focused approach leads to an average 13% weight loss in a year, e...

Virta Health's 60% Revenue Surge Driven by Employer Demand for Cost-Effective Weight Loss Solutions

Virta Health, a digital diabetes and weight loss program, achieved 60% revenue growth in 2024, exceeding $100 million, due to increasing employer demand for cost-effective alternatives to expensive GLP-1 drugs; the company's nutrition-focused approach leads to an average 13% weight loss in a year, e...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary factor driving the significant revenue growth experienced by Virta Health in 2024?

Virta Health, a digital diabetes program, experienced a 60% revenue increase in 2024, exceeding $100 million. This growth is fueled by employers seeking cost-effective solutions to manage rising expenses for GLP-1 weight-loss drugs. The company's focus on nutritional counseling, resulting in 13% average weight loss in a year, is a key factor.

theguardian.com

🌐 85% Global Worthiness

Dec 30, 04:07

NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases

Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...

NHS Wait Times Fuel Unsafe Online Weight-Loss Drug Purchases

Britain's top GP warns that long waits for NHS weight-loss services are driving people to buy potentially unsafe drugs online, as some patients face up to five-year waits for specialist support, while the NHS rollout of Mounjaro, a key weight-loss jab, is scheduled for 12 years, impacting an estimat...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do inadequate funding and extended wait times for NHS obesity treatments contribute to the increased demand for and use of potentially unsafe, unregulated weight-loss drugs purchased online?

The increasing prevalence of obesity and inadequate NHS funding contribute to the growing demand for unregulated weight-loss drugs. The Medicines and Healthcare products Regulatory Agency (MHRA) highlights the dangers of counterfeit medications sold online, emphasizing the need for prescription-only access to these powerful medicines. This situation underscores a critical healthcare access gap and the potential for serious health consequences.

Showing 85 to 96 of 116 results